Nevro (NYSE:NVRO) and Boston Scientific (NYSE:BSX) announced today that they reached a settlement over intellectual property litigations. The settlement gives Boston Scientific the freedom to operate using the features and capabilities embodied in its current line of products for frequencies below 1,500 Hz, with Nevro given the freedom to operate using the features and capabilities […]
Implants
CVRx stock up on Street-beating Q2 sales, raised guidance
CVRx (Nasdaq:CVRX) shares were up this morning on second-quarter results that beat the consensus revenue forecast. The Minneapolis-based neuromodulation technology developer posted losses of $11.1 million, or 54¢ per share, on sales of just over $5 million for the three months ended June 30, 2022, for a more than $6 million bottom-line gain despite remaining […]
Smith+Nephew stock dives on Q2 results, lowered 2022 trading margin guidance
Smith+Nephew (NYSE:SNN) shares took a hit today as the company revealed in its second-quarter earnings that it lowered its 2022 forecast. SNN shares were down more than 11% to $25.85 apiece in morning trading today on the New York Stock Exchange. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device […]
Conmed stock dips on lowered guidance despite Street-beating Q2
Conmed (NYSE:CNMD) shares are down today on lowered 2022 guidance, even as its Q2 results beat Wall Street expectations. The Largo, Florida–based company posted losses of $168.3 million, or $5.65 per share, on sales of $277.2 million for the three months ended June 30, 2022, for a massive bottom-line slide deep into the red on […]
Nexus Spine launches cervical interbody system
Nexus Spine announced today that it began the beta launch of its Stable-C cervical interbody fusion implants with integrated anchoring blades. Salt Lake City-based Nexus Spine’s latest release adds to its growing line of Tranquil interbody offerings, which includes ALIF, PLIF, TLIF, steerable TLIF, DLIF, and standard cervical configurations. Tranquil is made of titanium engineered […]
Endotronix expands U.S. headquarters in Illinois
Endotronix today announced plans to relocate and expand its headquarters in Naperville, Illinois to support a commercial launch of its heart failure treatment devices. The company’s new building will significantly increase its manufacturing and operating capacity to grow its workforce by 30%. The new location also allows for continued expansion for its Cordella heart failure […]
Synchron completes its first U.S. human implant of brain-computer interface rivaling Elon Musk’s Neuralink
Synchron announced today that it completed its first-in-human brain-computer interface (BCI) implant in the U.S. The procedure, performed at Mount Sinai West in New York, represents the first such implant to occur in the U.S. using an endovascular BCI approach, which does not require invasive open-brain surgery. Dr. Shahram Majidi, assistant professor of neurosurgery, neurology […]
DyAnsys wins FDA clearance for neurostimulator that treats diabetic neuropathic pain
DyAnsys recently announced that its First Relief neurostimulation device received FDA clearance to treat pain from diabetic peripheral neuropathy. Palo Alto, California-based DyAnsys designed the wearable device, placed on the ear, to administer continuous pulses of low-level electrical current over several days, offering multiple treatments of up to 56 days for symptomatic relief of chronic, […]
Medtronic warns on some Cobalt and Crome ICDs
Medtronic (NYSE:MDT) issued an urgent field safety notice in Europe to warn of issues with some implantable cardioverter defibrillators (ICDs). The medtech giant warned healthcare professionals that there is the potential for reduced shock energy — around 79% of programmed energy — during high-voltage (HV) therapy for all Cobalt and Crome ICDs and cardiac resynchronization […]
Orthofix partners with LimaCorporate on hip dislocation solution
Orthofix Medical (Nasdaq:OFIX) announced today that it entered into a licensing partnership for the U.S. market with LimaCorporate. The licensing partnership aims to provide a novel solution for patients with the challenging condition of chronic high dislocation of the hip. It will combine the limb-lengthening technology of Orthofix’s Fitbone intramedullary nail system with LimaCorporate’s proprietary, […]
CVRx launches new Barostim programmer in U.S.
CVRx (Nasdaq:CVRX) announced that it launched its new Barostim programmer following its approval by the FDA earlier this year. Minneapolis-based CVRx designed its second-generation programmer to operate on an upgraded cellular network to enable remote view access. It also includes an improved user interface that simplifies implantable pulse generator (IPG) programming. According to a news […]